Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIFFANY: FE 999302 for Final Follicular Maturation in Infertility
NCT05571111Phase 2Withdrawn
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2022
- Primary completion
- Mar 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of choriogonadotropin beta in infertility, sponsored by Ferring Pharmaceuticals. Planned start Oct 2022; status: withdrawn.
02
Drugs
choriogonadotropin beta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05571111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05571111.